Polyether-substituted porphyrin anti-tumor agents
US5622685A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jun 7, 1995 |
| Grant date | Apr 22, 1997 |
| Priority date | — |
| Expiry date | Jun 7, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2123/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Tumor-active or tumor-diagnostic substances having preferred accumulation in the tumor, which are characterized in that they have PA1 at least two phenolic hydroxyl and/or amino groups, PA1 at least one aliphatic amino group, or PA1 at least one phenolic hydroxyl and/or amino group and PA1 at least one aliphatic amino group and that these groups are substituted with polyethylene glycol chains whose polymerization degree n is 5 to 250 and whose terminal hydroxyl group is substituted by C.sub.1 -C.sub.12 alkyl ester or ether, each of the substances being substituted by at least two such polyethylene glycol chains.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.